Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Human ESC-based modeling of H3.3G34R-mutant high grade glioma

ABSTRACT: Human ESC-based modeling of H3.3G34R-mutant high grade glioma

PROVIDER: PRJNA615218 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR11424500_1.fastq.gz	Fastqsanger.gz
	SRR11424500_2.fastq.gz	Fastqsanger.gz
	SRR11424501_1.fastq.gz	Fastqsanger.gz
	SRR11424501_2.fastq.gz	Fastqsanger.gz
	SRR11424502_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 46

Similar Datasets

Human ESC-based modeling of H3.3G34R-mutant high grade glioma

Project description:H3.3G34R-mutant gliomas are lethal tumors of the cerebral hemispheres, with unknown mechanisms of topographic specificity and tumorigenicity. We developed a human embryonic stem cell (hESC)-based model of H3.3G34R-mutant glioma that recapitulates the anatomical and genetic characteristics of the patient tumors.

2021-02-25 | GSE147543 | GEO

Modeling Malignant Progression in Glioma

Project description:Modeling Malignant Progression in Glioma

| PRJNA767071 | ENA

Modeling Malignant Progression in Glioma

Project description:Modeling Malignant Progression in Glioma

| PRJNA762123 | ENA

Modeling Malignant Progression in Glioma

Project description:Modeling Malignant Progression in Glioma

| PRJNA762124 | ENA

CircGLIS3 promotes high-grade glioma invasion via modulating Ezrin phosphorylation

Project description:High-grade glioma is highly aggressive and malignant, resistant to combined therapies and easy to relapse. A better understanding of circRNA biological function in high-grade glioma might contribute to the therapeutic efficacy. Here, a circRNA merely up-regulated in high-grade glioma, circGLIS3 (hsa_circ_0002874, originating from exon 2 of GLIS3), was validated by microarray and qRT-PCR. Functional experiments uncovered that up-regulation of circGLIS3 promoted glioma cell migration and invasion, and showed aggressive characteristics in tumor-bearing mice. Fluorescence in situ hybridization, RNA pull-down, RNA immunoprecipitation and immunohistochemical staining showed that circGLIS3 could promoted Ezrin T567 phosphorylation. Further investigation showed that circGLIS3 could be excreted by glioma through exosomes and induced endothelial cells angiogenesis. This study indicates that circGLIS3 is up-regulated in high-grade glioma and contributes to the invasion and angiogenesis of glioma via promoting Ezrin T567 phosphorylation.

2021-09-22 | GSE165859 | GEO

Modeling Malignant Progression in Glioma

Project description:Gliomas are the most common primary brain tumor in humans. Low-grade gliomas (WHO grade II) invariably progress to high-grade gliomas (WHO grade III or IV). Although malignant progression may take many years, the survival rate after transformation to a high-grade glioma is poor, often only 12-15 months. In this data set, we have identified low-grade gliomas that have progressed to high-grade gliomas or high-grade gliomas that have progressed from low-grade gliomas. Some cases are matched pairs (meaning we have both the original low-grade tumor and the subsequent high-grade tumor). The samples deposited have been analyzed with bulk-RNA sequencing. They are also de-identified but are clinically annotated. When available, genetic information including IDH mutation status, 1p/19q deletion and histological subtype are also included.

2021-09-30 | GSE184941 | GEO

CircGLIS3 promotes high-grade glioma invasion via modulating Ezrin phosphorylation (microarray)

2021-09-22 | GSE165926 | GEO

RNA seq of mouse low grade glioma tumors

Project description:RNA sequencing was performed on paraffin embedded mouse low grade glioma tumor tissue

2022-09-12 | GSE172391 | GEO

Amplification of KRAS in a low grade glioma

Project description:We describe the case of a low grade glioma in a 37 year old male patient showing an amplification of KRAS

2016-11-18 | GSE89982 | GEO

A model of molecular characteristics to classify WHO Grade III glioma patients

Project description:Combing WHO classification and molecular characteristics to analysis gliomas more and more important. But Grade III glioma samples have a big difference within the group had not been reported as far as we know. In this study, we proposed a model to evaluate diagnosis and prognosis of Grade III glioma patients, and two independent datasets indicated that the model has a good predictive ability. Therefore, this strategy provides a new method to assist diagnosis and treatment of Grade III glioma patients.

2020-07-15 | GSE109857 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data